Literature DB >> 25605878

Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Maria A Riolo1, Pejman Rohani2.   

Abstract

Pertussis has reemerged as a major public health concern in many countries where it was once considered well controlled. Although the mechanisms responsible for continued pertussis circulation and resurgence remain elusive and contentious, many countries have nevertheless recommended booster vaccinations, the timing and number of which vary widely. Here, using a stochastic, age-stratified transmission model, we searched for cost-effective booster vaccination strategies using a genetic algorithm. We did so assuming four hypothesized mechanisms underpinning contemporary pertussis epidemiology: (I) insufficient coverage, (II) frequent primary vaccine failure, (III) waning of vaccine-derived protection, and (IV) vaccine "leakiness." For scenarios I-IV, successful booster strategies were identified and varied considerably by mechanism. Especially notable is the inability of booster schedules to alleviate resurgence when vaccines are leaky. Critically, our findings argue that the ultimate effectiveness of vaccine booster schedules will likely depend on correctly pinpointing the causes of resurgence, with misdiagnosis of the problem epidemiologically ineffective and economically costly.

Entities:  

Keywords:  booster schedule; genetic algorithm; immunization; pertussis

Mesh:

Substances:

Year:  2015        PMID: 25605878      PMCID: PMC4321240          DOI: 10.1073/pnas.1415573112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries.

Authors:  H Broutin; C Viboud; B T Grenfell; M A Miller; P Rohani
Journal:  Proc Biol Sci       Date:  2010-06-09       Impact factor: 5.349

2.  Acellular vaccines and resurgence of pertussis.

Authors:  Eugene D Shapiro
Journal:  JAMA       Date:  2012-11-28       Impact factor: 56.272

3.  Waning immunity to pertussis following 5 doses of DTaP.

Authors:  Sara Y Tartof; Melissa Lewis; Cynthia Kenyon; Karen White; Andrew Osborn; Juventila Liko; Elizabeth Zell; Stacey Martin; Nancy E Messonnier; Thomas A Clark; Tami H Skoff
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

4.  Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study.

Authors:  D Jenkinson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

5.  Strategy for rubella vaccination.

Authors:  E G Knox
Journal:  Int J Epidemiol       Date:  1980-03       Impact factor: 7.196

Review 6.  The increasing application of multiplex nucleic acid detection tests to the diagnosis of syndromic infections.

Authors:  J Gray; L J Coupland
Journal:  Epidemiol Infect       Date:  2013-10-07       Impact factor: 4.434

Review 7.  Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.

Authors:  F R Mooi; N A T Van Der Maas; H E De Melker
Journal:  Epidemiol Infect       Date:  2013-02-13       Impact factor: 4.434

8.  Estimating the duration of pertussis immunity using epidemiological signatures.

Authors:  Helen J Wearing; Pejman Rohani
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

9.  Global immunization: status, progress, challenges and future.

Authors:  Philippe Duclos; Jean-Marie Okwo-Bele; Marta Gacic-Dobo; Thomas Cherian
Journal:  BMC Int Health Hum Rights       Date:  2009-10-14

10.  Economic evaluation of human papillomavirus vaccination in the United Kingdom.

Authors:  Mark Jit; Yoon Hong Choi; W John Edmunds
Journal:  BMJ       Date:  2008-07-17
View more
  17 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Effectiveness of pertussis vaccination and duration of immunity.

Authors:  Kevin L Schwartz; Jeffrey C Kwong; Shelley L Deeks; Michael A Campitelli; Frances B Jamieson; Alex Marchand-Austin; Therese A Stukel; Laura Rosella; Nick Daneman; Shelly Bolotin; Steven J Drews; Heather Rilkoff; Natasha S Crowcroft
Journal:  CMAJ       Date:  2016-09-26       Impact factor: 8.262

3.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

4.  Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.

Authors:  J C Blackwood; D A T Cummings; S Iamsirithaworn; P Rohani
Journal:  Epidemics       Date:  2016-03-19       Impact factor: 4.396

5.  Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity.

Authors:  F M G Magpantay; M Domenech DE Cellès; P Rohani; A A King
Journal:  Parasitology       Date:  2015-09-04       Impact factor: 3.234

Review 6.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

7.  Delay in booster schedule as a control parameter in vaccination dynamics.

Authors:  Zhen Wang; Gergely Röst; Seyed M Moghadas
Journal:  J Math Biol       Date:  2019-09-07       Impact factor: 2.259

8.  Use of a 40-day rolling incidence to monitor pertussis in Nova Scotia, 2015.

Authors:  B Born; A Coombs; V Ryan; M LaFreniere; L Earle; S Fleming; A Fitzgerald; F Atherton
Journal:  Can Commun Dis Rep       Date:  2017-02-02

9.  Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.

Authors:  Nasamon Wanlapakorn; Varisara Ngaovithunvong; Thanunrat Thongmee; Preeyaporn Vichaiwattana; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-02-02       Impact factor: 3.240

10.  Hand, Foot, and Mouth Disease in China: Critical Community Size and Spatial Vaccination Strategies.

Authors:  Thomas P Van Boeckel; Saki Takahashi; Qiaohong Liao; Weijia Xing; Shengjie Lai; Victor Hsiao; Fengfeng Liu; Yaming Zheng; Zhaorui Chang; Chen Yuan; C Jessica E Metcalf; Hongjie Yu; Bryan T Grenfell
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.